Koers Manzo Pharmaceuticals, Inc. Other OTC
Aandelen
MNZO
US56510D1063
Farmaceutische producten
Omzet 2003 | 3 mln. 2,79 mln. | Omzet 2004 | 3,07 mln. 2,85 mln. | Marktkapitalisatie | 8,07K 7,5K |
---|---|---|---|---|---|
Nettowinst (verlies) 2003 | -3 mln. -2,79 mln. | Nettowinst (verlies) 2004 | -4 mln. -3,72 mln. | EV/omzet 2003 | - |
Nettoschuld 2003 | 7,3 6,79 | Nettoschuld 2004 | 6,51 6,05 | EV/omzet 2004 | - |
K/w-verhouding 2003 |
-0,73
x | K/w-verhouding 2004 |
-0,42
x | Werknemers | - |
Dividendrendement 2003 * |
-
| Dividendrendement 2004 |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,48% | 71,19 mld. | |
+12,55% | 9,3 mld. | |
-13,75% | 5,01 mld. | |
+42,38% | 4,47 mld. | |
+4,51% | 3,96 mld. | |
+21,10% | 2,44 mld. | |
-19,05% | 2,41 mld. | |
-28,72% | 2,23 mld. | |
+11,13% | 2,02 mld. |